Clinical Trial Update: Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant chemotherapy trial evaluating gemcitabine, cisplatin, and sunitinib (GC-S) for muscle-invasive bladder cancer; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Sunitinib (sunitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer, Urinary Bladder | Phase 2 | Status: COMPLETED | Results posted: 2016-02-29